ArticleEndocrine2013
Serum 25-hydroxyvitamin D status in individuals with psoriasis in the general population.
Article in Endocrine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis.Nutrients · 2023Pooled it
- Comparing Vitamin D Level Between Patients with Psoriasis and Healthy Individuals: A Systematic Review and Meta-Analysis.Journal of evidence-based integrative medicinePooled it
- Non-Skeletal Roles of Vitamin D in Skin, Gut, and Cardiovascular Disease: Focus on Epithelial Barrier Function and Immune Regulation in Chronic Disease.International journal of molecular sciences · 2025Review
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases.International journal of molecular sciences · 2025Review
- Oral and topical vitamin D treatment strategies in psoriasis.Skin health and disease · 2025Review
- Association of serum vitamin D levels and psoriasis severity: an analysis of the US National health and nutrition examination survey.Archives of dermatological research · 2025Article
- Skin Disorders and Osteoporosis: Unraveling the Interplay Between Vitamin D, Microbiota, and Epigenetics Within the Skin-Bone Axis.International journal of molecular sciences · 2024Review
- The Expression of Vitamin D Receptor on Peripheral Blood Mononuclear Cells in Patients with Psoriasis.International journal of molecular sciences · 2024Article
- Low Vitamin K Status in Patients with Psoriasis Vulgaris: A Pilot Study.Biomedicines · 2024Article
- Relationship between genetically proxied vitamin D and psoriasis risk: a Mendelian randomization study.Clinical and experimental dermatology · 2023Article
- Association of rs1544410 and rs7975232 Polymorphisms and Serum Vitamin D Levels with Psoriasis Susceptibility and Severity: A Case-Control Study in Egyptian Patients.Clinical, cosmetic and investigational dermatology · 2022Article
- The Effects of Vitamin D on the Expression of IL-33 and Its Receptor ST2 in Skin Cells; Potential Implication for Psoriasis.International journal of molecular sciences · 2021Article
- Hypovitaminosis D is Associated with Psoriasis: A Systematic Review and Meta-Analysis.Kansas journal of medicine · 2019Article
- Observational
- Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.Endocrine · 2015Article
- Prevalence of chronic axial pain, inflammatory back pain, and spondyloarthritis in diagnosed psoriasis.Arthritis care & research · 2015Article
- Correlation of Vitamin D3 Levels with Disease Severity in Psoriasis Patients - A Case-Control Study.Indian journal of dermatologyArticle
- Association of Vitamin D Deficiency with Psoriasis and Metabolic Syndrome: A Case-Control Study in Indian Patients.Indian journal of dermatologyArticle
- Low Vitamin D in Psoriasis: Reality or Myth?Indian journal of dermatologyArticle
- Association between Vitamin D deficiency and psoriasis: An exploratory study.International journal of health sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a dearth of data assessing serum 25-hydroxyvitamin D (25[OH]D) status in psoriasis. This population-based study in the United States evaluated 25(OH)D status in psoriasis and examined the associations between 25(OH)D and psoriasis severity. The 2003-2006 National Health and Nutrition Examination Survey was analyzed. Participants aged 20-59 years self-reported psoriasis, psoriasis body surface area (BSA), and psoriasis life impairment (PLI). Serum 25(OH)D was assessed with the DiaSorin radioimmunoassay. General linear models were used to examine the associations between psoriasis and 25(OH)D while accounting for age, gender, race/ethnicity, season, and body mass index (BMI). Among the 5,841 participants with complete data, 148 reported a psoriasis diagnosis. Mean 25(OH)D levels and deficiency prevalences (<20 and <30 ng/mL) were not different between those with and without psoriasis. Among those with psoriasis, a multivariate model showed participants with BSA >10 hand palms trended towards lower 25(OH)D compared to those with minimal BSA (-4.98 ng/mL, P = 0.07). PLI was not associated with 25(OH)D, but BMI showed an inverse association with 25(OH)D (coefficient = -0.40, P < 0.001). In summary, dermatologists may consider measures of adiposity as better screening tools for vitamin D deficiency than BSA involvement among psoriatics with mild-to-moderate disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.